HYSTEROSCOPIC MYOMECTOMY

Ricardo Bassil Lasmar; Bernardo Portugal Lasmar; Nash S. Moawad

doi:10.3390/medicina58111627

Medicina (Nov 2022)

HYSTEROSCOPIC MYOMECTOMY

Ricardo Bassil Lasmar,
Bernardo Portugal Lasmar,
Nash S. Moawad

Affiliations

Ricardo Bassil Lasmar: Department of Surgery and Specialized, Faculty of Medicine, Universidade Federal Fluminense, UFF, Niterói 24020-141, RJ, Brazil
Bernardo Portugal Lasmar: University of the Maternal-Infant Department of the Faculty of Medicine, Universidade Federal Fluminense, UFF, Niterói 24020-141, RJ, Brazil
Nash S. Moawad: Division of Minimally Invasive Gynecologic Surgery, Department of Obstetrics & Gynecology, P.O. Box 100294, Gainesville, FL 32610, USA

DOI: https://doi.org/10.3390/medicina58111627
Journal volume & issue: Vol. 58, no. 11
p. 1627

Abstract

Read online

Leiomyomas are the most common pelvic tumors. Submucosal fibroids are a common cause of abnormal bleeding and infertility. Hysteroscopic myomectomy is the definitive management of symptomatic submucosal fibroids, with high efficacy and safety. Several techniques have been introduced over time and will be covered in depth in this manuscript. Advances in optics, fluid management, electrosurgery, smaller diameter scopes, and tissue removal systems, along with improved training have contributed to improving the safety and efficiency of hysteroscopic myomectomy.

Published in Medicina

ISSN: 1010-660X (Print); 1648-9144 (Online)
Publisher: MDPI AG
Country of publisher: Switzerland
LCC subjects: Medicine: Medicine (General)
Website: https://www.mdpi.com/journal/medicina

About the journal

Abstract

Keywords